Apr 25, 2023, 11:40 by

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization (CDMO), today announced financial results for the first quarter of fiscal year 2023.

Apr 25, 2023, 11:40 by

Apr 25, 2023, 11:40 by

Apr 25, 2023, 11:40 by

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Apr 25, 2023, 11:40 by

Indica Labs and Lunit has announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP® image management software platform and Lunit’s suite of AI pathology products.

Apr 25, 2023, 01:00 by User Not Found

Clinical Research News | PCORI has announced $127M in investment for research projects targeting high-burden healthcare concerns; Gilde Healthcare announces a new fund for medtech; Series C for a FHIR-native health data platform; and more.

Apr 20, 2023, 01:00 by User Not Found

Clinical Research News | Post-traumatic stress disorder is difficult to diagnose under the best of conditions, including knowing the triggering issues and how an individual responds to stressful events. For the mostly young and “macho” men in the military who are exposed to combat and separated from their families for many months at a stretch the obstacles—and stakes—are even higher.

Apr 18, 2023, 01:00 by User Not Found

Clinical Research News | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.

Apr 14, 2023, 01:00 by User Not Found

Clinical Research News | Artificial Intelligence (AI-) powered software is demonstrating great potential to accelerate and improve participant screening and enrolment in clinical trials. It is also enhancing communication and collaboration between clinical research teams. These elements combined are resulting in improved productivity and better ROI for clinical trials.

Apr 13, 2023, 10:59 by

Meridian Medical Technologies, a Kindeva Drug Delivery Company, a leading global contract development and manufacturing organization (CDMO) focused on drug-device combination products, announced today, during National Community Development Week, it will expand manufacturing capabilities in Bridgeton, Missouri — investing more than $100 million over the next four years in a newly purchased facility. Meridian, which recently combined with Kindeva, will be converting this new 155,000-square-foot facility to support increased production of drug-device combination products, sterile fill-finish capabilities, and create job opportunities in the St. Louis area.

Apr 13, 2023, 10:59 by

Unique platform enables providers to securely connect life science organizations to rich patient data to test hypotheses, develop clinical trials, and create life saving therapies

Apr 13, 2023, 10:57 by

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency

Apr 13, 2023, 10:56 by

CD Bioparticles has launched a range of reversed-phase chromatography resins with different monodisperse particle sizes.

Apr 13, 2023, 10:55 by

STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.

Apr 13, 2023, 10:54 by

Creative Diagnostics recently introduced comprehensive contract ELISA kit development services to the R&D and IVD communities.

Apr 13, 2023, 10:51 by

PEGylation is a revolutionary modification of a therapeutic protein, nucleic acid, or small drug molecule by covalently attaching polyethylene glycol (PEG) or a derivative thereof.

Apr 13, 2023, 10:49 by

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

Apr 12, 2023, 01:00 by User Not Found

Clinical Research News | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.

Apr 11, 2023, 01:01 by User Not Found

Clinical Research News | A small company based in Norway is taking on the global-sized challenge of cancer treatment, notably including solid tumors and hematological malignancies. The means is a promising, highly specific drug, known as ATX-101, whose molecular target orchestrates many different processes in the cells.

Apr 7, 2023, 12:12 by

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.